Debra Hughes, MS, Author at MPR - Page 2 of 40

Debra Hughes, MS

All articles by Debra Hughes, MS

Adjuvant PegIFN/RBV Ups Survival in HCV/HCC Patients Receiving TACE

In patients with chronic hepatitis C virus (HCV) infection and intermediate stage hepatocellular carcinoma (HCC) who receive transarterial chemoembolization (TACE), the SVR achieved with pegylated-interferon (pegIFN/ribavirin (RBV) treatment markedly improved survival and reduced tumor recurrence, a study presented at The Liver Meeting 2016® concluded.